Role of autophagy in the maintenance and function of cancer stem cells

International Journal of Developmental Biology

Volumn 59, Issue 1-3, 2015, Pages 95-108

  Vitale, Ilio ^a,b   Manic, Gwenola ^a   Dandrea, Vito ^a   De Maria, Ruggero ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Autophagosomes; Beclin 1; CD133; Chloroquine; Lysosomes; Tumor initiating cells

Indexed keywords

CD133 ANTIGEN;

ARTICLE; AUTOPHAGY; CANCER RECURRENCE; CANCER STEM CELL; CARCINOGENESIS; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL POPULATION; CELL SPREADING; CELL SURVIVAL; EPIGENETICS; HEREDITY; HUMAN; HUMAN CELL; LYSOSOME; MACROAUTOPHAGY; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; APOPTOSIS; CELL COMMUNICATION; CELL TRANSFORMATION; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; AUTOPHAGY; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 84940639171     PISSN: 02146282     EISSN: 16963547     Source Type: Journal    
DOI: 10.1387/ijdb.150082iv     Document Type: Article

References (265)

1. AUA, V.M, LIANG, X.H, MURTY, V.V, PINCUS, D.L, YU, W, CAYANIS, E, KA-Lachikov, S, GILLIAM, T.C. and LEVINE, B. (1999). Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59: 59-65.
2. AL-Hajj, M, WICHA, M.S, BENITO-Hernandez, A, MORRISON, S.J. and CLARKE, M.F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988.
3. ALISON, M.R, LIN, W.R, LIM, S.M. and NICHOLSON, L.J. (2012). Cancer stem cells: in the line of fire. Cancer Treat Rev 38: 589-598.
4. ALTMAN, B.J, JACOBS, S.R, MASON, E.F, MICHALEK, R.D, MACINTYRE, A.N, COLOFF, J.L, ILKAYEVA, O, JIA, W, HE, Y.W. and RATHMELL, J.C. (2011). Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis. Oncogene 30: 1855-1867.
5. AMARAVADI, R.K, LIPPINCOTT-Schwartz, J, YIN, X.M, WEISS, W.A, TAKEBE, N, TIMMER, W, DIPAOLA, R.S, LOTZE, M.T. and WHITE, E. (2011). Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17: 654-666.
6. AXE, E.L, WALKER, S.A, MANIFAVA, M, CHANDRA, P, RODERICK, H.L, HABERMANN, A, GRIFFITHS, G. and KTISTAKIS, N.T. (2008). Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol 182: 685-701.
7. BACCELLI, I. and TRUMPP, A. (2012). The evolving concept of cancer and metastasis stem cells. J Cell Biol 198: 281-293.
8. BALIC, A, SORENSEN, M.D, TRABULO, S.M, SAINZ, B, JR, CIOFFI, M, VIEIRA, C.R, MIRANDA-Lorenzo, I, HIDALGO, M, KLEEFF, J, ERKAN, M. et al, (2014). Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling. Mol Cancer Ther 13: 1758-1771.
9. BAO, S, WU, Q, MCLENDON, R.E, HAO, Y, SHI, Q, HJELMELAND, A.B, DE-Whirst, M.W, BIGNER, D.D. and RICH, J.N. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
10. BARTUCCI, M, DATTILO, R, MORICONI, C, PAGLIUCA, A, MOTTOLESE, M, FEDERICI, G, BENEDETTO, A.D, TODARO, M, STASSI, G, SPERATI, F. et al, (2015). TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells. Oncogene 34: 681-690.
11. BARTUCCI, M, SVENSSON, S, ROMANIA, P, DATTILO, R, PATRIZII, M, SIGNORE, M, NAVARRA, S, LOTTI, F, BIFFONI, M, PILOZZI, E. et al, (2012). Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy. Cell Death Differ 19: 768-778.
12. BECK, B. and BLANPAIN, C. (2013). Unravelling cancer stem cell potential. Nat Rev Cancer 13: 727-738.
13. BELLODI, C, LIDONNICI, M.R, HAMILTON, A, HELGASON, G.V, SOLIERA, A.R, RONCHETTI, M, GALAVOTTI, S, YOUNG, K.W, SELMI, T, YACOBI, R. et al, (2009). Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest 119: 1109-1123.
14. BERRY, D.L. and BAEHRECKE, E.H. (2007). Growth arrest and autophagy are required for salivary gland cell degradation in Drosophila. Cell 131: 1137-1148.
15. BIASOLI, D, KAHN, S.A, CORNELIO, T.A, FURTADO, M, CAMPANATI, L, CHNEI-Weiss, H, MOURA-Neto, V. and BORGES, H.L. (2013). Retinoblastoma proteinregulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide. Cell Death Dis 4: e767.
16. BIRGISDOTTIR, A.B, LAMARK, T. and JOHANSEN, T. (2013). The LIR motif-crucial for selective autophagy. J Cell Sci 126: 3237-3247.
17. BONNET, D. and DICK, J.E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med3: 730-737.
18. BOYA, P, GONZALEZ-Polo, R.A, CASARES, N, PERFETTINI, J.L, DESSEN, P., LAROCHETTE, N, METIVIER, D, MELEY, D, SOUQUERE, S, YOSHIMORI, T. et al, (2005). Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25: 1025-1040.
19. BOYER, L.A, LEE, T.I, COLE, M.F, JOHNSTONE, S.E, LEVINE, S.S, ZUCKER, J.P, GUENTHER, M.G, KUMAR, R.M, MURRAY, H.L, JENNER, R.G. et al, (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956.
20. CAO, Y. and KLIONSKY, D.J. (2007). Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res 17: 839-849.
21. CAPPER, D, GAISER, T, HARTMANN, C, HABEL, A, MUELLER, W, HEROLD-Mende, C, VON DEIMLING, A. and SIEGELIN, M.D. (2009). Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation. Acta Neuropathol 117: 445-456.
22. CHAFFER, C.L, BRUECKMANN, I, SCHEEL, C, KAESTLI, A.J, WIGGINS, P.A.,RODRIGUES, L.O, BROOKS, M, REINHARDT, F, SU, Y, POLYAK, K. et al, (2011). Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA 108: 7950-7955.
23. CHAFFER, C.L, MARJANOVIC, N.D, LEE, T, BELL, G, KLEER, C.G, REINHARDT, F, DALESSIO, A.C, YOUNG, R.A. and WEINBERG, R.A. (2013). Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154: 61-74.
24. CHANG, L, GRAHAM, P.H, HAO, J, NI, J, BUCCI, J, COZZI, P.J, KEARSLEY, J.H. and LI, Y. (2013). Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Dis 4: e875.
25. CHATERJEE, M. and VAN GOLEN, K.L. (2011). Breast cancer stem cells survive periods of farnesyl-transferase inhibitor-induced dormancy by undergoing au-tophagy. Bone Marrow Res 2011: 362938.
26. CHEN, H, LUO, Z, DONG, L, TAN, Y, YANG, J, FENG, G, WU, M, LI, Z. and WANG, H. (2013a). CD133/prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell survival. PLoS One 8: e56878.
27. CHEN, H, LUO, Z, SUN, W, ZHANG, C, SUN, H, ZHAO, N, DING, J, WU, M, LI, Z. and WANG, H. (2013b). Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cells. Cancer Lett 336: 204-212.
28. CHEN, J, LI, Y, YU, T.S, MCKAY, R.M, BURNS, D.K, KERNIE, S.G. and PARADA, L.F. (2012). A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488: 522-526.
29. CHEN, S. and GUAN, J.L. (2013). Tumor-promoting and-suppressive roles of autophagy in the same mouse model of BrafV600E-driven lung cancer. Cancer Discov 3: 1225-1227.
30. CHEN, T. and DENT, S.Y. (2014). Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat Rev Genet 15: 93-106.
31. CHEN, Y, LU, Y, LU, C. and ZHANG, L. (2009). Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression. Pathol Oncol Res 15: 487-493.
32. CHO, Y.Y, KIM, D.J, LEE, H.S, JEONG, C.H, CHO, E.J, KIM, M.O, BYUN, S, LEE, K.Y, YAO, K, CARPER, A. et al, (2013). Autophagy and cellular senescence mediated by Sox2 suppress malignancy of cancer cells. PLoS One 8: e57172.
33. CHOI, A.M, RYTER, S.W. and LEVINE, B. (2013). Autophagy in human health and disease. N Engl J Med 368: 651-662.
34. CHOI, D.S, BLANCO, E, KIM, Y.S, RODRIGUEZ, A.A, ZHAO, H, HUANG, T.H, CHEN, C.L, JIN, G, LANDIS, M.D, BUREY, L.A. et al, (2014). Chloroquine Eliminates Cancer Stem Cells Through Deregulation of Jak2 and DNMT1. Stem Cells 32: 2309-2323.
35. CLARK, S.L, JR. (1957). Cellular differentiation in the kidneys of newborn mice studies with the electron microscope. J Biophys Biochem Cytol 3: 349-362.
36. CLEMENT, V, DUTOIT, V, MARINO, D, DIETRICH, P.Y. and RADOVANOVIC, I. (2009). Limits of CD133 as a marker of glioma self-renewing cells. Int J Cancer125: 244-248.
37. COJOC, M, MABERT, K, MUDERS, M.H. and DUBROVSKA, A. (2015). A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms. Semin Cancer Biol. 31: 16-27.
38. COLLINS, A.T, BERRY, P.A, HYDE, C, STOWER, M.J. and MAITLAND, N.J. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
39. CONLEY, S.J, GHEORDUNESCU, E, KAKARALA, P, NEWMAN, B, KORKAYA, H, HEATH, A.N, CLOUTHIER, S.G. and WICHA, M.S. (2012). Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci USA 109: 2784-2789.
40. CUFI, S, VAZQUEZ-Martin, A, OLIVERAS-Ferraros, C, MARTIN-Castillo, B, VELLON, L. and MENENDEZ, J.A. (2011). Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype. Cell Cycle 10: 3871-3885.
41. CURTIS, S.J, SINKEVICIUS, K.W, LI, D, LAU, A.N, ROACH, R.R, ZAMPONI, R, WOOLFENDEN, A.E, KIRSCH, D.G, WONG, K.K. and KIM, C.F. (2010). Primary tumor genotype is an important determinant in identification of lung cancer propagating cells. Cell Stem Cell 7: 127-133.
42. DE SOUSA, E.M.F, VERMEULEN, L, FESSLER, E. and MEDEMA, J.P. (2013). Cancer heterogeneity--a multifaceted view. EMBO Rep 14: 686-695.
43. DEGENHARDT, K, MATHEW, R, BEAUDOIN, B, BRAY, K, ANDERSON, D, CHEN, G, MUKHERJEE, C, SHI, Y, GELINAS, C, FAN, Y. et al, (2006). Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigen-esis. Cancer Cell 10: 51-64.
44. DENTON, D, NICOLSON, S. and KUMAR, S. (2012). Cell death by autophagy: facts and apparent artefacts. Cell Death Differ 19: 87-95.
45. DENTON, D, SHRAVAGE, B, SIMIN, R, MILLS, K, BERRY, D.L, BAEHRECKE, E.H. and KUMAR, S. (2009). Autophagy, not apoptosis, is essential for midgut cell death in Drosophila. Curr Biol 19: 1741-1746.
46. DIETER, S.M, BALL, C.R, HOFFMANN, C.M, NOWROUZI, A, HERBST, F, ZAVIDIJ, O, ABEL, U, ARENS, A, WEICHERT, W, BRAND, K. et al, (2011). Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 9: 357-365.
47. DING, Z.B, SHI, Y.H, ZHOU, J, QIU, S.J, XU, Y, DAI, Z, SHI, G.M, WANG, X.Y, KE, A.W, WU, B. et al, (2008). Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res 68: 9167-9175.
48. DRIESSENS, G, BECK, B, CAAUWE, A, SIMONS, B.D. and BLANPAIN, C. (2012). Defining the mode of tumour growth by clonal analysis. Nature 488: 527-530.
49. DUBROVSKA, A, KIM, S, SALAMONE, R.J, WALKER, J.R, MAIRA, S.M, GARCIA-Echeverria, C, SCHULTZ, P.G. and REDDY, V.A. (2009). The role of PTEN/ Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 106: 268-273.
50. EGAN, D.F, SHACKELFORD, D.B, MIHAYLOVA, M.M, GELINO, S, KOHNZ, R.A, MAIR, W, VASQUEZ, D.S, JOSHI, A, GWINN, D.M, TAYLOR, R. et al, (2011). Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331: 456-461.
51. ELZINGA, B.M, NYHAN, M.J, CROWLEY, L.C, ODONOVAN, T.R, CAHILL, M.R. and MCKENNA, S.L. (2013). Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein. Am J Hematol88: 455-462.
52. ERAMO, A, LOTTI, F, SETTE, G, PILOZZI, E, BIFFONI, M, DI VIRGILIO, A, CONTICELLO, C, RUCO, L, PESCHLE, C. and DE MARIA, R. (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514.
53. ERAMO, A, RICCI-Vitiani, L, ZEUNER, A, PALLINI, R, LOTTI, F, SETTE, G, PILOZZI, E, LAROCCA, L.M, PESCHLE, C. and DE MARIA, R. (2006). Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 13: 1238-1241.
54. RDELYI, P, BORSOS, E, TAKACS-Vellai, K, KOVACS, T, KOVACS, A.L, SIGMOND, T, HARGITAI, B, PASZTOR, L, SENGUPTA, T, DENGG, M. et al, (2011). Shared developmental roles and transcriptional control of autophagy and apoptosis in Caenorhabditis elegans. J Cell Sci 124: 1510-1518.
55. ESPINA, V, MARIANI, B.D, GALLAGHER, R.I, TRAN, K, BANKS, S, WIEDEMANN, J, HURYK, H, MUELLER, C, ADAMO, L, DENG, J. et al, (2010). Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival. PLoS One 5: e10240.
56. FADER, C.M, SANCHEZ, D.G, MESTRE, M.B. and COLOMBO, M.I. (2009).TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways. Biochim Biophys Acta 1793: 1901-1916.
57. FILIPPI-Chiela, E.C, VILLODRE, E.S, ZAMIN, L.L. and LENZ, G. (2011).Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS One 6: e20849.
58. FIRAT, E, WEYERBROCK, A, GAEDICKE, S, GROSU, A.L. and NIEDERMANN, G. (2012). Chloroquine or chloroquine-PI3K/Akt pathway inhibitor combinations strongly promote gamma-irradiation-induced cell death in primary stem-like glioma cells. PLoS One 7: e47357.
59. FRANCESCANGELI, F, PATRIZII, M, SIGNORE, M, FEDERICI, G, DI FRANCO, S, PAGLIUCA, A, BAIOCCHI, M, BIFFONI, M, RICCI VITIANI, L, TODARO, M. et al, (2012). Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells. Stem Cells 30: 1819-1830.
60. FRANCIPANE, M.G. and LAGASSE, E. (2013). Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1. Oncotarget 4: 1948-1962.
61. FU, J, LIU, Z.G, LIU, X.M, CHEN, F.R, SHI, H.L, PANGJESSE, C.S, NG, H.K. and CHEN, Z.P. (2009). Glioblastoma stem cells resistant to temozolomide-induced autophagy. Chin Med J (Engl) 122: 1255-1259.
62. FU, Y, CHANG, H, PENG, X, BAI, Q, YI, L, ZHOU, Y, ZHU, J. and MI, M. (2014). Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/beta-catenin signaling pathway. PLoS One 9: e102535.
63. FUNDERBURK, S.F, WANG, Q.J. and YUE, Z. (2010). The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond. Trends Cell Biol 20: 355-362.
64. FURUYA, N, YU, J, BYFIELD, M, PATTINGRE, S. and LEVINE, B. (2005). The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, au-tophagy and tumor suppressor function. Autophagy 1: 46-52.
65. GALAVOTTI, S, BARTESAGHI, S, FACCENDA, D, SHAKED-Rabi, M, SANZONE, S, MCEVOY, A, DINSDALE, D, CONDORELLI, F, BRANDNER, S, CAMPANELLA, M. et al, (2013). The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene 32: 699-712.
66. GALLUZZI, L, BRAVO-San PEDRO J.M, VITALE I, AARONSON, S.A. ABRAMS, J.M. ADAM, D, ALNEMRI E.S. ALTUCCI L ANDREWS D, ANNICCHIARICO-Petruzzelli, M. et al, (2015). Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 22: 58-73.
67. GALLUZZI, L, KEPP, O, VANDER HEIDEN, M.G. and KROEMER, G. (2013). Metabolic targets for cancer therapy. Nat Rev Drug Discov 12: 829-846.
68. GALLUZZI, L, PIETROCOLA, F, LEVINE, B. and KROEMER, G. (2014). Metabolic Control of Autophagy. Cell 159: 1263-1276.
69. GALLUZZI, L, VITALE, I, ABRAMS, J.M, ALNEMRI, E.S, BAEHRECKE, E.H, BLA-Gosklonny, M.V, DAWSON, T.M, DAWSON, V.L, EL-Deiry, W.S, FULDA, S. et al, (2012). Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19: 107-120.
70. GANLEY, I.G, LAM DU, H, WANG, J, DING, X, CHEN, S. and JIANG, X. (2009). ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 284: 12297-12305.
71. GARNER, J.M, FAN, M, YANG, C.H, DU, Z, SIMS, M, DAVIDOFF, A.M. and PFEFFER, L.M. (2013). Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappaB signaling in glioblastoma cancer stem cells regulates the Notch pathway. J Biol Chem 288: 26167-26176.
72. GERLINGER, M, ROWAN, A.J, HORSWELL, S, LARKIN, J, ENDESFELDER, D, GRONROOS, E, MARTINEZ, P, MATTHEWS, N, STEWART, A, TARPEY, P. et al, (2012). Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366: 883-892.
73. GIANNONI, E, BIANCHINI, F, MASIERI, L, SERNI, S, TORRE, E, CALORINI, L. and CHIARUGI, P. (2010). Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 70: 6945-6956.
74. GINESTIER, C, HUR, M.H, CHARAFE-Jauffret, E, MONVILLE, F, DUTCHER, J, BROWN, M, JACQUEMIER, J, VIENS, P, KLEER, C.G, LIU, S. et al, (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
75. GOLEBIEWSKA, A, BRONS, N.H, BJERKVIG, R. and NICLOU, S.P. (2011). Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell 8: 136-147.
76. GONG, C, BAUVY, C, TONELLI, G, YUE, W, DELOMENIE, C, NICOLAS, V, ZHU Y, DOMERGUE, V, MARIN-Esteban, V, THARINGER, H. et al, (2013). Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/ progenitor cells. Oncogene 32: 2261-2272.
77. GORDON, D.J, RESIO, B. and PELLMAN, D. (2012). Causes and consequences of aneuploidy in cancer. Nat Rev Genet 13: 189-203.
78. GRANDER, D, KHARAZIHA, P, LAANE, E, POKROVSKAJA, K. and PANARETA-Kis, T. (2009). Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies. Autophagy 5: 1198-1200.
79. GREAVES, M. (2013). Cancer stem cells as ‘units of selection’. Evol App l6: 102-108.
80. GREEN, D.R. and LEVINE, B. (2014). To be or not to be? How selective autophagy and cell death govern cell fate. Cell 157: 65-75.
81. GRIGUER, C.E, OLIVA, C.R, GOBIN, E, MARCORELLES, P, BENOS, D.J, LANCATER, J.R JR. and GILLESPIE, G.Y. (2008). CD133 is a marker of bioenergetic stress in human glioma. PLoS One 3: e3655.
82. GUAN, J.L, SIMON, A.K, PRESCOTT, M, MENENDEZ, J.A, LIU, F, WANG, F, WANG, C, WOLVETANG, E, VAZQUEZ-Martin, A. and ZHANG, J. (2013). Autophagy in stem cells. Autophagy 9: 830-849.
83. GUO, J.Y, CHEN, H.Y, MATHEW, R, FAN, J, STROHECKER, A.M, KARSLI-Uzunbas, G, KAMPHORST, J.J, CHEN, G, LEMONS, J.M, KARANTZA, V. et al, (2011). Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25: 460-470.
84. GUO, J.Y, KARSLI-Uzunbas, G, MATHEW, R, AISNER, S.C, KAMPHORST, J.J, STROHECKER, A.M, CHEN, G, PRICE, S, LU, W, TENG, X. et al, (2013). Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev 27: 1447-1461.
85. GUPTA, P.B, FILLMORE, C.M, JIANG, G, SHAPIRA, S.D, TAO, K, KUPERWASSER, C. and LANDER, E.S. (2011). Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146: 633-644.
86. GUPTA, P.B, ONDER, T.T, JIANG, G, TAO, K, KUPERWASSER, C, WEINBERG, R.A. and LANDER, E.S. (2009). Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645-659.
87. GWINN, D.M, SHACKELFORD, D.B, EGAN, D.F, MIHAYLOVA, M.M, MERY, A, VASQUEZ, D.S, TURK, B.E. and SHAW, R.J. (2008). AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30: 214-226.
88. HAMASAKI, M, FURUTA, N, MATSUDA, A, NEZU, A, YAMAMOTO, A, FUJITA, N, OOMORI, H, NODA, T, HARAGUCHI, T, HIRAOKA, Y. et al, (2013). Autophagosomes form at ER-mitochondria contact sites. Nature 495: 389-393.
89. HANAHAN, D. and COUSSENS, L.M. (2012). Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21: 309-322.
90. HANAHAN, D. and WEINBERG, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144: 646-674.
91. HARDIE, D.G, ROSS, F.A. and HAWLEY, S.A. (2012). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13: 251-262.
92. HAYASHI-Nishino, M, FUJITA, N, NODA, T, YAMAGUCHI, A, YOSHIMORI, T. and YAMAMOTO, A. (2009). A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat Cell Biol 11: 1433-1437.
93. HEDDLESTON, J.M, LI, Z, MCLENDON, R.E, HJELMELAND, A.B. and RICH, J.N. (2009). The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8: 3274-3284.
94. HEMMATI, H.D, NAKANO, I, LAZAREFF, J.A, MASTERMAN-Smith, M, GESCHWIND, D.H, BRONNER-Fraser, M. and KORNBLUM, H.I. (2003). Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100: 15178-15183.
95. HERMANN, P.C, HUBER, S.L, HERRLER, T, AICHER, A, ELLWART, J.W, GUBA, M, BRUNS, C.J. and HEESCHEN, C. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323.
96. HIRSCH, H.A, ILIOPOULOS, D, TSICHLIS, P.N. and STRUHL, K. (2009). Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69: 7507-7511.
97. HOSOKAWA, N, HARA, T, KAIZUKA, T, KISHI, C, TAKAMURA, A, MIURA, Y, IEMURA, S, NATSUME, T, TAKEHANA, K, YAMADA, N. et al, (2009). Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell20: 1981-1991.
98. HUANG, J.J, ZHU, Y.J, LIN, T.Y, JIANG, W.Q, HUANG, H.Q. and LI, Z.M. (2011). Beclin 1 expression predicts favorable clinical outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP. Hum Pathol42: 1459-1466.
99. HUO, Y, CAI, H, TEPLOVA, I, BOWMAN-Colin, C, CHEN, G, PRICE, S, BARNARD, N, GANESAN, S, KARANTZA, V, WHITE, E. et al, (2013). Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer. Cancer Discov 3: 894-907.
100. IANNELLO, A. and RAULET, D.H. (2014). Immunosurveillance of senescent cancer cells by natural killer cells. Oncoimmunology 3: e27616.
101. IANNELLO, A, THOMPSON, T.W, ARDOLINO, M, LOWE, S.W. and RAULET, D. H. (2013). p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. J Exp Med 210: 2057-2069.
102. ILIOPOULOS, D, HIRSCH, H.A, WANG, G. and STRUHL, K. (2011). Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc Natl Acad Sci USA 108: 1397-1402.
103. INAMI, Y, WAGURI, S, SAKAMOTO, A, KOUNO, T, NAKADA, K, HINO, O, WATANABE, S, ANDO, J, IWADATE, M, YAMAMOTO, M. et al, (2011). Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol 193: 275-284.
104. INOKI, K, ZHU, T. and GUAN, K.L. (2003). TSC2 mediates cellular energy response to control cell growth and survival. Cell 115: 577-590.
105. ISHIZAWA, K, RASHEED, Z.A, KARISCH, R, WANG, Q, KOWALSKI, J, SUSKY, E. , PEREIRA, K, KARAMBOULAS, C, MOGHAL, N, RAJESHKUMAR, N.V. et al, (2010). Tumor-initiating cells are rare in many human tumors. Cell Stem Cell 7: 279-282.
106. JAIN, A, LAMARK, T, SJOTTEM, E, LARSEN, K.B, AWUH, J.A, OVERVATN, A, MCMAHON, M, HAYES, J.D. and JOHANSEN, T. (2010). p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285: 22576-22591.
107. JIANG, H, GOMEZ-Manzano, C, AOKI, H, ALONSO, M.M, KONDO, S, MC-Cormick, F, XU, J, KONDO, Y, BEKELE, B.N, COLMAN, H. et al, (2007). Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst 99: 1410-1414.
108. JIANG, Z.F, SHAO, L.J, WANG, W.M, YAN, X.B. and LIU, R.Y. (2012). Decreased expression of Beclin-1 and LC3 in human lung cancer. Mol Biol Rep 39: 259-267.
109. JOHANSEN, T. and LAMARK, T. (2011). Selective autophagy mediated by autophagic adapter proteins. Autophagy 7: 279-296.
110. JOPLING, C, BOUE, S. and IZPISUA BELMONTE, J.C. (2011). Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat Rev Mol Cell Biol 12: 79-89.
111. JUNG, C.H, JUN, C.B, RO, S.H, KIM, Y.M, OTTO, N.M, CAO, J, KUNDU, M. and KIM, D.H. (2009). ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 20: 1992-2003.
112. KANG, M.R, KIM, M.S, OH, J.E, KIM, Y.R, SONG, S.Y, KIM, S.S, AHN, C.H, YOO, N.J. and LEE, S.H. (2009). Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol 217: 702-706.
113. KANTARA, C, OCONNELL, M, SARKAR, S, MOYA, S, ULLRICH, R. and SINGH, P. (2014). Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1-siRNA. Cancer Res 74: 2487-2498.
114. KARANTZA-Wadsworth, V, PATEL, S, KRAVCHUK, O, CHEN, G, MATHEW, R, JIN, S. and WHITE, E. (2007). Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 21: 1621-1635.
115. KASTAN, M.B, SCHLAFFER, E, RUSSO, J.E, COLVIN, O.M, CIVIN, C.I. and HILTON, J. (1990). Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 75: 1947-1950.
116. KENDZIORRA, E, AHLBORN, K, SPITZNER, M, RAVE-Frank, M, EMONS, G, GAEDCKE, J, KRAMER, F, WOLFF, H.A, BECKER, H, BEISSBARTH, T. et al, (2011). Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. Carcinogenesis 32: 1824-1831.
117. KIM, H.S, LEE, S.H, DO, S.I, LIM, S.J, PARK, Y.K. and KIM, Y.W. (2011a). Clinico-pathologic correlation of beclin-1 expression in pancreatic ductal adenocarcinoma. Pathol Res Pract 207: 247-252.
118. KIM, J, KIM, Y.C, FANG, C, RUSSELL, R.C, KIM, J.H, FAN, W, LIU, R, ZHONG, Q. and GUAN, K.L. (2013). Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152: 290-303.
119. KIM, J, KUNDU, M, VIOLLET, B. and GUAN, K.L. (2011b). AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13: 132-141.
120. KIM, M.S, SONG, S.Y, LEE, J.Y, YOO, N.J. and LEE, S.H. (2011c). Expressional and mutational analyses of ATG5 gene in prostate cancers. APMIS 119: 802-807.
121. KIMMELMAN, A.C. (2011). The dynamic nature of autophagy in cancer. Genes Dev 25: 1999-2010.
122. KONG, Y, YOSHIDA, S, SAITO, Y, DOI, T, NAGATOSHI, Y, FUKATA, M, SAITO, N, YANG, S.M, IWAMOTO, C, OKAMURA, J. etal, (2008). CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia 22: 1207-1213.
123. KRESO, A. and DICK, J.E. (2014). Evolution of the cancer stem cell model. Cell Stem Cell 14: 275-291.
124. KRESO, A, OBRIEN, C.A, VAN GALEN, P, GAN, O.I, NOTTA, F, BROWN, A.M, NG, K, MA, J, WIENHOLDS, E, DUNANT, C. et al, (2013). Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 339: 543-548.
125. KROEMER, G, MARINO, G. and LEVINE, B. (2010). Autophagy and the integrated stress response. Mol Cell 40: 280-293.
126. KUMA, A. and MIZUSHIMA, N. (2010). Physiological role of autophagy as an intra-cellular recycling system: with an emphasis on nutrient metabolism. Semin Cell Dev Biol 21: 683-690.
127. KUMAR, D, SHANKAR, S. and SRIVASTAVA, R.K. (2013). Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms. Mol Cancer 12: 171.
128. KUMAR, D, SHANKAR, S. and SRIVASTAVA, R.K. (2014). Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway. Cancer Lett 343: 179-189.
129. LAANE, E, TAMM, K.P, BUENTKE, E, ITO, K, KHARAZIHA, P, OSCARSSON, J, CORCORAN, M, BJORKLUND, A.C, HULTENBY, K, LUNDIN, J. et al, (2009). Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ 16: 1018-1029.
130. LADDHA, S.V, GANESAN, S, CHAN, C.S. and WHITE, E. (2014). Mutational landscape of the essential autophagy gene BECN1 in human cancers. Mol Cancer Res 12: 485-490.
131. LAMB, C.A, YOSHIMORI, T. and TOOZE, S.A. (2013). The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol 14: 759-774.
132. LAMY, L, NGO, V.N, EMRE, N.C, SHAFFER, A.L 3RD, YANG, Y, TIAN, E, NAIR, V, KRUHLAK, M.J, ZINGONE, A, LANDGREN, O. et al, (2013). Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell 23: 435-449.
133. LAPIDOT, T, SIRARD, C, VORMOOR, J, MURDOCH, B, HOANG, T, CACERES-Cortes, J, MINDEN, M, PATERSON, B, CALIGIURI, M.A. and DICK, J.E. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648.
134. LAPLANTE, M. and SABATINI, D.M. (2012). mTOR signaling in growth control and disease. Cell 149: 274-293.
135. LAZOVA, R, CAMP, R.L, KLUMP, V, SIDDIQUI, S.F, AMARAVADI, R.K. and PAWELEK, J.M. (2012). Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin Cancer Res 18: 370-379.
136. LEVINE, B. and KROEMER, G. (2008). Autophagy in the pathogenesis of disease. Cell 132: 27-42.
137. LI, B.X, LI, C.Y, PENG, R.Q, WU, X.J, WANG, H.Y, WAN, D.S, ZHU, X.F. and ZHANG, X.S. (2009a). The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy 5: 303-306.
138. LI, C, LEE, C.J. and SIMEONE, D.M. (2009b). Identification of human pancreatic cancer stem cells. Methods Mol Biol 568: 161-173.
139. LIANG, X.H, JACKSON, S, SEAMAN, M, BROWN, K, KEMPKES, B, HIBSHOOSH, H. and LEVINE, B. (1999). Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676.
140. LIN, Q. and YUN, Z. (2010). Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics. Cancer Biol Ther 9: 949-956.
141. LIN, Y.H, HUANG, Y.C, CHEN, L.H. and CHU, P.M. (2015). Autophagy In cancer stem/progenitor cells. Cancer Chemother Pharmacol. 75: 879-886.
142. LIU, H, HE, Z, VON RUTTE, T, YOUSEFI, S, HUNGER, R.E. and SIMON, H.U. (2013). Down-regulation of autophagy-related protein 5 (ATG5) contributes to the pathogenesis of early-stage cutaneous melanoma. Sci Transl Med 5: 202ra123.
143. LOMONACO, S.L, FINNISS, S, XIANG, C, DECARVALHO, A, UMANSKY, F, KALKANIS, S.N, MIKKELSEN, T. and BRODIE, C. (2009). The induction of autophagy by gamma-radiation contributes to the radioresistant of glioma stem cells. Int J Cancer 125: 717-722.
144. MA, Y, LIANG, D, LIU, J, AXCRONA, K, KVALHEIM, G, STOKKE, T, NESLAND, J.M. and SUO, Z. (2011). Prostate cancer cell lines under hypoxia exhibit greater stem-like properties. PLoS One 6: e29170.
145. MAGEE, J.A, PISKOUNOVA, E. and MORRISON, S.J. (2012). Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21: 283-296.
146. MAI, T.T, MOON, J, SONG, Y, VIET, P.Q, PHUC, P.V, LEE, J.M, YI, T.H, CHO, M. and CHO, S.K. (2012). Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells. Cancer Lett 321: 144-153.
147. MANIC, G, OBRIST, F, KROEMER, G, VITALE, I. and GALLUZZI, L. (2014). Chloro-quine and hydroxychloroquine for cancer therapy. Molec. Cell. Oncol. 1: e29911.
148. MARI, M, GRIFFITH, J, RIETER, E, KRISHNAPPA, L, KLIONSKY, D.J. and REG-Giori, F. (2010). An Atg9-containing compartment that functions in the early steps of autophagosome biogenesis. J Cell Biol 190: 1005-1022.
149. MARINO, G, NISO-Santano, M, BAEHRECKE, E.H. and KROEMER, G. (2014). Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol 15: 81-94.
150. MARINO, G, SALVADOR-Montoliu, N, FUEYO, A, KNECHT, E, MIZUSHIMA, N. and LOPEZ-Otin, C. (2007). Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem 282: 18573-18583.
151. MARTELLI, A.M, EVANGELISTI, C, FOLLO, M.Y, RAMAZZOTTI, G, FINI, M, GIARDINO, R, MANZOLI, L, MCCUBREY, J.A. and COCCO, L. (2011). Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells. Curr Med Chem 18: 2715-2726.
152. MATHEW, R, KONGARA, S, BEAUDOIN, B, KARP, C.M, BRAY, K, DEGENHARDT, K, CHEN, G, JIN, S. and WHITE, E. (2007). Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev21: 1367-1381.
153. MATHIEU, J, ZHANG, Z, ZHOU, W, WANG, A.J, HEDDLESTON, J.M, PINNA, C.M, HUBAUD, A, STADLER, B, CHOI, M, BAR, M. et al, (2011). HIF induces human embryonic stem cell markers in cancer cells. Cancer Res 71: 4640-4652.
154. MAUGERI-Sacca, M, VIGNERI, P. and DE MARIA, R. (2011). Cancer stem cells and chemosensitivity. Clin Cancer Res 17: 4942-4947.
155. MAYCOTTE, P, ARYAL, S, CUMMINGS, C.T, THORBURN, J, MORGAN, M.J. and THORBURN, A. (2012). Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 8: 200-2012.
156. MCAULIFFE, S.M, MORGAN, S.L, WYANT, G.A, TRAN, L.T, MUTO, K.W, CHEN, Y.S, CHIN, K.T, PARTRIDGE, J.C, POOLE, B.B, CHENG, K.H. et al, (2012). Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc Natl Acad Sci USA 109: E2939-E2948.
157. MEACHAM, C.E. and MORRISON, S.J. (2013). Tumour heterogeneity and cancer cell plasticity. Nature 501: 328-337.
158. MEIJER, A.J. and KLIONSKY, D.J. (2011). Vps34 is a phosphatidylinositol 3-kinase, not a phosphoinositide 3-kinase. Autophagy 7: 563-564.
159. MICHAUD, M, MARTINS, I, SUKKURWALA, A.Q, ADJEMIAN, S, MA, Y, PEL-Legatti, P, SHEN, S, KEPP, O, SCOAZEC, M, MIGNOT, G. et al, (2011). Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334: 1573-1577.
160. MICHELS, J, OBRIST, F, CASTEDO, M, VITALE, I. and KROEMER, G. (2015). PARP and other prospective targets for poisoning cancer cell metabolism. Biochem Pharmacol. 92: 164-171.
161. MIZUSHIMA, N. (2010). The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol 22: 132-139
162. MIZUSHIMA, N. and KOMATSU, M. (2011). Autophagy: renovation of cells and tissues. Cell 147: 728-741.
163. MIZUSHIMA, N, LEVINE, B, CUERVO, A.M. and KLIONSKY, D.J. (2008). Autophagy fights disease through cellular self-digestion. Nature 451: 1069-1075.
164. MIZUSHIMA, N, YOSHIMORI, T. and OHSUMI, Y. (2011). The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 27: 107-132.
165. MOHAMMED, A, JANAKIRAM, N.B, BREWER, M, RITCHIE, R.L, MARYA, A, LIGHTFOOT, S, STEELE, V.E. and RAO, C.V. (2013). Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling. Transl Oncol 6: 649-659.
166. MOHYELDIN, A, GARZON-Muvdi, T. and QUINONES-Hinojosa, A. (2010). Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7: 150-161.
167. MORSELLI, E, GALLUZZI, L, KEPP, O, MARINO, G, MICHAUD, M, VITALE, I, MAIURI, M.C. and KROEMER, G. (2011). Oncosuppressive functions of autophagy. Antioxid Redox Signal 14: 2251-2269.
168. NAIR, U, JOTWANI, A, GENG, J, GAMMOH, N, RICHERSON, D, YEN, W.L, GRIFFITH, J, NAG, S, WANG, K, MOSS, T. et al, (2011). SNARE proteins are required for macroautophagy. Cell 146: 290-302.
169. NAKATOGAWA, H, ICHIMURA, Y. and OHSUMI, Y. (2007). Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion. Cell 130: 165-178.
170. NEZIS, I.P, SHRAVAGE, B.V, SAGONA, A.P, LAMARK, T, BJORKOY, G, JOHANSEN, T, RUSTEN, T.E, BRECH, A, BAEHRECKE, E.H. and STENMARK, H. (2010). Autophagic degradation of dBruce controls DNA fragmentation in nurse cells during late Drosophila melanogaster oogenesis. J Cell Biol 190: 523-531.
171. NGUYEN, L.V, VANNER, R, DIRKS, P. and EAVES, C.J. (2012). Cancer stem cells: an evolving concept. Nat Rev Cancer 12: 133-143.
172. NIXON, R.A. (2013). The role of autophagy in neurodegenerative disease. Nat Med 19: 983-997.
173. NODA, T, FUJITA, N. and YOSHIMORI, T. (2008). The Ubi brothers reunited. Autophagy 4: 540-541.
174. ODONOVAN, T.R, OSULLIVAN, G.C. and MCKENNA, S.L. (2011). Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 7: 509-524.
175. OHSUMI, Y. (2001). Molecular dissection of autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol 2: 211-216.
176. OJHA, R, JHA, V, SINGH, S.K. and BHATTACHARYYA, S. (2014). Autophagy inhibition suppresses the tumorigenic potential of cancer stem cell enriched side population in bladder cancer. Biochim Biophys Acta 1842: 2073-2086.
177. PALLINI, R, RICCI-Vitiani, L, BANNA, G.L, SIGNORE, M, LOMBARDI, D, TODARO, M, STASSI, G, MARTINI, M, MAIRA, G, LAROCCA, L.M. et al, (2008). Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 14: 8205-8212.
178. PARKHITKO, A, MYACHINA, F, MORRISON, T.A, HINDI, K.M, AURICCHIO, N, KARBOWNICZEK, M, WU, J.J, FINKEL, T, KWIATKOWSKI, D.J, YU, J.J. et al, (2011). Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent. Proc Natl Acad Sci USA 108: 12455-12460.
179. PATRAWALA, L, CALHOUN, T, SCHNEIDER-Broussard, R, LI, H, BHATIA, B, TANG, S, REILLY, J.G, CHANDRA, D, ZHOU, J, CLAYPOOL, K. et al, (2006). Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25: 1696-1708.
180. PATTINGRE, S, TASSA, A, QU, X, GARUTI, R, LIANG, X.H, MIZUSHIMA, N, PACKER, M, SCHNEIDER, M.D. and LEVINE, B. (2005). Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122: 927-939.
181. PECE, S, TOSONI, D, CONFALONIERI, S, MAZZAROL, G, VECCHI, M, RONZONI, S, BERNARD, L, VIALE, G, PELICCI, P.G. and DI FIORE, P.P. (2010). Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140: 62-73.
182. PHADWAL, K, WATSON, A.S. and SIMON, A.K. (2013). Tightrope act: autophagy in stem cell renewal, differentiation, proliferation, and aging. Cell Mol Life Sci 70: 89-103.
183. PHILLIPS, T.M, MCBRIDE, W.H. and PAJONK, F. (2006). The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777-1785.
184. PIRTOLI, L, CEVENINI, G, TINI, P, VANNINI, M, OLIVERI, G, MARSILI, S, MOURMOURAS, V, RUBINO, G. and MIRACCO, C. (2009). The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy 5: 930-936.
185. POLSON, H.E, DE LARTIGUE, J, RIGDEN, D.J, REEDIJK, M, URBE, S, CLAGUE, M.J. and TOOZE, S.A. (2010). Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation. Autophagy 6: 506-522.
186. QIANG, L, WU, T, ZHANG, H.W, LU, N, HU, R, WANG, Y.J, ZHAO, L, CHEN, F.H, WANG, X.T, YOU, Q.D. et al, (2012). HIF-1alpha is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway. Cell Death Differ 19: 284-294.
187. QU, X, YU, J, BHAGAT, G, FURUYA, N, HIBSHOOSH, H, TROXEL, A, ROSEN, J, ESKELINEN, E.L, MIZUSHIMA, N, OHSUMI, Y. et al, (2003). Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112: 1809-1820.
188. QUINTANA, E, SHACKLETON, M, FOSTER, H.R, FULLEN, D.R, SABEL, M.S, JOHNSON, T.M. and MORRISON, S.J. (2010). Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18: 510-523.
189. QUINTANA, E, SHACKLETON, M, SABEL, M.S, FULLEN, D.R, JOHNSON, T.M. and MORRISON, S.J. (2008). Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
190. RAO, R, BALUSU, R, FISKUS, W, MUDUNURU, U, VENKANNAGARI, S, CHAUHAN, L, SMITH, J.E, HEMBRUFF, S.L, HA, K, ATADJA, P. et al, (2012). Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells. Mol Cancer Ther 11: 973-983.
191. RAO, S, TORTOLA, L, PERLOT, T, WIRNSBERGER, G, NOVATCHKOVA, M, NITSCH, R, SYKACEK, P, FRANK, L, SCHRAMEK, D, KOMNENOVIC, V. et al, (2014). A dual role for autophagy in a murine model of lung cancer. Nat Commun 5: 3056.
192. RAUSCH, V, LIU, L, APEL, A, RETTIG, T, GLADKICH, J, LABSCH, S, KALLIFATIDIS, G, KACZOROWSKI, A, GROTH, A, GROSS, W. et al, (2012). Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment. J Pathol 227: 325-335.
193. RAVIKUMAR, B, MOREAU, K, JAHREISS, L, PURI, C. and RUBINSZTEIN, D.C. (2010). Plasma membrane contributes to the formation of pre-autophagosomal structures. Nat Cell Biol 12: 747-757.
194. RELLO-Varona, S, LISSA, D, SHEN, S, NISO-Santano, M, SENOVILLA, L, MARINO, G, VITALE, I, JEMAA, M, HARPER, F, PIERRON, G. et al, (2012). Autophagic removal of micronuclei. Cell Cycle 11: 170-176.
195. REYA, T, MORRISON, S.J, CLARKE, M.F. and WEISSMAN, I.L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414: 105-11.
196. RICCI-Vitiani, L, LOMBARDI, D.G, PILOZZI, E, BIFFONI, M, TODARO, M, PESCHLE, C. and DE MARIA, R. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-5.
197. RICCI-Vitiani, L, PALLINI, R, LAROCCA, L.M, LOMBARDI, D.G, SIGNORE, M, PIERCONTI, F, PETRUCCI, G, MONTANO, N, MAIRA, G. and DE MARIA, R. (2008). Mesenchymal differentiation of glioblastoma stem cells. Cell Death Differ 15: 1491-8.
198. ROESCH, A, FUKUNAGA-Kalabis, M, SCHMIDT, E.C, ZABIEROWSKI, S.E, BRAFFORD, P.A, VULTUR, A, BASU, D, GIMOTTY, P, VOGT, T. and HERLYN, M. (2010). A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141: 583-94.
199. ROSENFELDT, M.T, OPREY, J, MORTON, J.P, NIXON, C, MACKAY, G, MROWINSKA, A, AU, A, RAI, T.S, ZHENG, L, RIDGWAY, R. et al, (2013). p53 status determines the role of autophagy in pancreatic tumour development. Nature 504: 296-300.
200. ROTHE, K, LIN, H, LIN, K.B, LEUNG, A, WANG, H.M, MALEKESMAEILI, M, BRINKMAN, R.R, FORREST, D.L, GORSKI, S.M. and JIANG, X. (2014). The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells. Blood 123: 3622-34.
201. RUBINSZTEIN, D.C, CODOGNO, P. and LEVINE, B. (2012). Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11: 709-30.
202. RUBINSZTEIN, D.C, MARINO, G. and KROEMER, G. (2011). Autophagy and aging. Cell 146: 682-95.
203. RUSSELL, R.C, TIAN, Y, YUAN, H, PARK, H.W, CHANG, Y.Y, KIM, J, KIM, H., NEUFELD, T.P, DILLIN, A. and GUAN, K.L. (2013). ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol 15: 741-50.
204. SASAKI, K, TSUNO, N.H, SUNAMI, E, TSURITA, G, KAWAI, K, OKAJI, Y, NISHIKAWA, T, SHUNO, Y, HONGO, K, HIYOSHI, M. et al, (2010). Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells. BMC Cancer 10: 370.
205. SCHEPERS, A.G, SNIPPERT, H.J, STANGE, D.E, VAN DEN BORN, M, VAN ES, J.H, VAN DE WETERING, M. and CLEVERS, H. (2012). Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337: 730-735.
206. SCHULZE, A. and HARRIS, A.L. (2012). How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491: 364-373.
207. SELVAKUMARAN, M, AMARAVADI, R.K, VASILEVSKAYA, I.A. and ODWYER, P.J. (2013). Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy. Clin Cancer Res 19: 2995-3007.
208. SHACKLETON, M, QUINTANA, E, FEARON, E.R. and MORRISON, S.J. (2009). Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138: 822-829.
209. SHARMA, S.V, LEE, D.Y, LI, B, QUINLAN, M.P, TAKAHASHI, F, MAHESWARAN, S, MCDERMOTT, U, AZIZIAN, N, ZOU, L, FISCHBACH, M.A. et al, (2010). A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141: 69-80.
210. SHRAVAGE, B.V, HILL, J.H, POWERS, C.M, WU, L. and BAEHRECKE, E.H. (2013). Atg6 is required for multiple vesicle trafficking pathways and hematopoiesis in Drosophila. Development 140: 1321-1329.
211. SINGH, B.N, KUMAR, D, SHANKAR, S. and SRIVASTAVA, R.K. (2012). Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem Pharmacol 84: 1154-1163.
212. SINGH, S.K, HAWKINS, C, CLARKE, I.D, SQUIRE, J.A, BAYANI, J, HIDE, T, HENKELMAN, R.M, CUSIMANO, M.D. and DIRKS, P.B. (2004). Identification of human brain tumour initiating cells. Nature 432: 396-401.
213. SONG, Y.J, ZHANG, S.S, GUO, X.L, SUN, K, HAN, Z.P, LI, R, ZHAO, Q.D, DENG, W.J, XIE, X.Q, ZHANG, J.W. et al, (2013). Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. Cancer Lett 339: 70-81.
214. SONG, Z, YUE, W, WEI, B, WANG, N, LI, T, GUAN, L, SHI, S, ZENG, Q, PEI, X. and CHEN, L. (2011). Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer. PLoS One 6: e17687.
215. SUN, L, MATHEWS, L.A, CABARCAS, S.M, ZHANG, X, YANG, A, ZHANG, Y, YOUNG, M.R, KLARMANN, K.D, KELLER, J.R. and FARRAR, W.L. (2013). Epigenetic regulation of SOX9 by the NF-kappaB signaling pathway in pancreatic cancer stem cells. Stem Cells 31: 1454-1466.
216. SUVA, M.L, RIGGI, N. and BERNSTEIN, B.E. (2013). Epigenetic reprogramming in cancer. Science 339: 1567-1570.
217. TAKAHASHI, Y, MEYERKORD, C.L, HORI, T, RUNKLE, K, FOX, T.E, KESTER, M, LOUGHRAN, T.P. and WANG, H.G. (2011). Bif-1 regulates Atg9 trafficking by mediating the fission of Golgi membranes during autophagy. Autophagy 7: 61-73.
218. TAKAMURA, A, KOMATSU, M, HARA, T, SAKAMOTO, A, KISHI, C, WAGURI, S, EISHI, Y, HINO, O, TANAKA, K. and MIZUSHIMA, N. (2011). Autophagy-deficient mice develop multiple liver tumors. Genes Dev 25: 795-800.
219. TAKEBE, N, HARRIS, P.J, WARREN, R.Q. and IVY, S.P. (2011). Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol 8: 97-106.
220. THUMM, M, EGNER, R, KOCH, B, SCHLUMPBERGER, M, STRAUB, M, VEENHUIS, M. and WOLF, D.H. (1994). Isolation of autophagocytosis mutants of Saccharomyces cerevisiae. FEBS Lett 349: 275-280.
221. TODARO, M, ALEA, M.P, DI STEFANO, A.B, CAMMARERI, P, VERMEULEN, L, IOVINO, F, TRIPODO, C, RUSSO, A, GULOTTA, G, MEDEMA, J.P. et al, (2007). Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1: 389-402.
222. TODARO, M, GAGGIANESI, M, CATALANO, V, BENFANTE, A, IOVINO, F, BIFFONI, M, APUZZO, T, SPERDUTI, I, VOLPE, S, COCORULLO, G. et al, (2014). CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell 14: 342-356.
223. TONG, Y, LIU, Y.Y, YOU, L.S. and QIAN, W.B. (2012). Perifosine induces protective autophagy and upregulation of ATG5 in human chronic myelogenous leukemia cells in vitro. Acta Pharmacol Sin 33: 542-550.
224. TSUKADA, M. and OHSUMI, Y. (1993). Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett 333: 169-174.
225. ULASOV, I.V, NANDI, S, DEY, M, SONABEND, A.M. and LESNIAK, M.S. (2011). Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. Mol Med 17: 103-112.
226. VANDER HEIDEN, M.G, CANTLEY, L.C. and THOMPSON, C.B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
227. VERMEULEN, L DE, SOUSA E MELO F, RICHEL, D.J. and MEDEMA, J.P. (2012). The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol 13: e83-e89.
228. VERMEULEN, L, DE SOUSA, E.M.F, VAN DER HEIJDEN, M, CAMERON, K, DE JONG, J.H, BOROVSKI, T, TUYNMAN, J.B, TODARO, M, MERZ, C, RODERMOND, H. et al, (2010). Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12: 468-476.
229. VESSONI, A.T, MUOTRI, A.R. and OKAMOTO, O.K. (2012). Autophagy in stem cell maintenance and differentiation. Stem Cells Dev 21: 513-520.
230. VIALE, A, PETTAZZONI, P, LYSSIOTIS, C.A, YING, H, SANCHEZ, N, MARCHESINI, M, CARUGO, A, GREEN, T, SETH, S, GIULIANI, V. et al, (2014). Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514: 628-632.
231. VITALE, I, GALLUZZI, L, CASTEDO, M. and KROEMER, G. (2011a). Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 12: 385-392.
232. VITALE, I, GALLUZZI, L, SENOVILLA, L, CRIOLLO, A, JEMAA, M, CASTEDO, M. and KROEMER, G. (2011b). Illicit survival of cancer cells during polyploidization and depolyploidization. Cell Death Differ 18: 1403-1413.
233. WAN, X.B, FAN, X.J, CHEN, M.Y, XIANG, J, HUANG, P.Y, GUO, L, WU, X.Y, XU, J, LONG, Z.J, ZHAO, Y. et al, (2010). Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy 6: 395-404.
234. WANG, J, SAKARIASSEN, P.O, TSINKALOVSKY, O, IMMERVOLL, H, BOE, S.O, SVENDSEN, A, PRESTEGARDEN, L, ROSLAND, G, THORSEN, F, STUHR, L. et al, (2008). CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122: 761-768.
235. WANG, Y, WANG, X.D, LAPI, E, SULLIVAN, A, JIA, W, HE, Y.W, RATNAYAKA, I, ZHONG, S, GOLDIN, R.D, GOEMANS, C.G. et al, (2012). Autophagic activity dictates the cellular response to oncogenic RAS. Proc Natl Acad Sci USA 109: 13325-13330.
236. WEI, H, WEI, S, GAN, B, PENG, X, ZOU, W. and GUAN, J.L. (2011). Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev 25: 1510-1527.
237. WEI, Y, JIANG, Y, ZOU, F, LIU, Y, WANG, S, XU, N, XU, W, CUI, C, XING, Y, CAO, B. et al, (2013a). Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells. Proc Natl Acad Sci USA 110: 6829-6834.
238. WEI, Y, ZOU, Z, BECKER, N, ANDERSON, M, SUMPTER, R, XIAO, G, KINCH, L, KODURU, P, CHRISTUDASS, C.S, VELTRI, R.W. et al, (2013b). EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell 154: 1269-1284.
239. WEIDBERG, H, SHPILKA, T, SHVETS, E, ABADA, A, SHIMRON, F. and ELAZAR, Z. (2011). LC3 and GATE-16 N termini mediate membrane fusion processes required for autophagosome biogenesis. Dev Cell 20: 444-454.
240. WEIDBERG, H, SHVETS, E, SHPILKA, T, SHIMRON, F, SHINDER, V. and ELAZAR, Z. (2010). LC3 and GATE-16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J 29: 1792-1802.
241. WHITE, E. (2012). Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12: 401-410.
242. WIRTH, M, JOACHIM, J. and TOOZE, S.A. (2013). Autophagosome formation--the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage. Semin Cancer Biol 23: 301-309.
243. WOLF, J, DEWI, D.L, FREDEBOHM, J, MULLER-Decker, K, FLECHTENMACHER, C, HOHEISEL, J.D. and BOETTCHER, M. (2013). A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype. Breast Cancer Res 15: R109.
244. WU, S, WANG, X, CHEN, J. and CHEN, Y. (2013). Autophagy of cancer stem cellsis involved with chemoresistance of colon cancer cells. Biochem Biophys Res Commun 434: 898-903.
245. XIE, R, WANG, F, MCKEEHAN, W.L. and LIU, L. (2011). Autophagy enhanced by microtubule-and mitochondrion-associated MAP1S suppresses genome instability and hepatocarcinogenesis. Cancer Res 71: 7537-7546.
246. XUE, W, ZENDER, L, MIETHING, C, DICKINS, R.A, HERNANDO, E, KRIZHANOVSKY, V, CORDON-Cardo, C. and LOWE, S.W. (2007). Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656-660.
247. YANG, S, WANG, X, CONTINO, G, LIESA, M, SAHIN, E, YING, H, BAUSE, A, LI, Y, STOMMEL, J.M, DELLANTONIO, G. et al, (2011a). Pancreatic cancers require autophagy for tumor growth. Genes Dev 25: 717-729.
248. YANG, Z. and KLIONSKY, D.J. (2010). Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 22: 124-131.
249. YANG, Z, ZHANG, L, MA, A, LIU, L, LI, J, GU, J. and LIU, Y. (2011b). Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations. PLoS One 6: e28405.
250. YENIGUN, V.B, OZPOLAT, B. and KOSE, G.T. (2013). Response of CD44+/CD24-/low breast cancer stem/progenitor cells to tamoxifen and doxorubicininduced autophagy. Int J Mol Med 31: 1477-1483.
251. YOULE, R.J. and NARENDRA, D.P. (2011). Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12: 9-14.
252. YOUNG, A.R, NARITA, M, FERREIRA, M, KIRSCHNER, K, SADAIE, M, DAROT, J.F, TAVARE, S, ARAKAWA, S, SHIMIZU, S, WATT, F.M. et al, (2009). Autophagy mediates the mitotic senescence transition. Genes Dev 23: 798-803.
253. YU, Y, YANG, L, ZHAO, M, ZHU, S, KANG, R, VERNON, P, TANG, D. and CAO, L. (2012). Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells. Leukemia 26: 1752-1760.
254. YUE, W, HAMAI, A, TONELLI, G, BAUVY, C, NICOLAS, V, THARINGER, H, CODOGNO, P. and MEHRPOUR, M. (2013). Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance. Autophagy 9: 714-729.
255. YUE, Z, JIN, S, YANG, C, LEVINE, A.J. and HEINTZ, N. (2003). Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 100: 15077-15082.
256. ZENG, M. and ZHOU, J.N. (2008). Roles of autophagy and mTOR signaling in neuronal differentiation of mouse neuroblastoma cells. Cell Signal 20: 659-665.
257. ZEUNER, A, FRANCESCANGELI, F, CONTAVALLI, P, ZAPPARELLI, G, APUZZO, T, ERAMO, A, BAIOCCHI, M, DE ANGELIS, M.L, BIFFONI, M, SETTE, G. et al, (2014a). Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-X inhibition in non-small cell lung cancer. Biochem Pharmacol 92: 164-171.
258. ZEUNER, A, TODARO, M, STASSI, G. and DE MARIA, R. (2014b). Colorectal Cancer Stem Cells: From the Crypt to the Clinic. Cell Stem Cell 15: 692-705.
259. ZHAO, Y, HUANG, Q, YANG, J, LOU, M, WANG, A, DONG, J, QIN, Z. and ZHANG, T. (2010). Autophagy impairment inhibits differentiation of glioma stem/progenitor cells. Brain Res 1313: 250-258.
260. ZHOU, J, WULFKUHLE, J, ZHANG, H, GU, P, YANG, Y, DENG, J, MARGOLICK, J.B, LIOTTA, L.A, PETRICOIN, E BRD and ZHANG, Y. (2007). Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci USA 104: 16158-16163.
261. ZHU, H, WANG, D, LIU, Y, SU, Z, ZHANG, L, CHEN, F, ZHOU, Y, WU, Y, YU, M, ZHANG, Z. et al, (2013). Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells. Cancer Cell Int 13: 119.
262. ZHU, H, WANG, D, ZHANG, L, XIE, X, WU, Y, LIU, Y, SHAO, G. and SU, Z. (2014). Upregulation of autophagy by hypoxia-inducible factor-1alpha promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia. Oncol Rep 32: 935-942.
263. ZHUANG, W, LI, B, LONG, L, CHEN, L, HUANG, Q. and LIANG, Z. (2011a). Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. Int J Cancer 129: 2720-2731.
264. ZHUANG, W, LI, B, LONG, L, CHEN, L, HUANG, Q. and LIANG, Z.Q. (2011b). Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy. Brain Res 1371: 7-15.
265. ZHUANG, W.Z, LONG, L.M, JI, W.J. and LIANG, Z.Q. (2011c). Rapamycin induces differentiation of glioma stem/progenitor cells by activating autophagy. Chin J Cancer 30: 712-720.